| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/12/2005 | CN1562352A Technique for producing injection of freeze drying powder of A type botulinus toxin in use for treatment, and formula of protectant of freeze drying powder |
| 01/12/2005 | CN1562345A Drug combination including activator for metabolism of brain and free radical scavenger |
| 01/12/2005 | CN1562339A Method for preparing pharmaceutics of hydrolysate of brain protein |
| 01/12/2005 | CN1562336A Solid effervesce decoction pieces from ganoderma lucidum |
| 01/12/2005 | CN1562325A Preparation of Chinese traditional medicine for refreshment and preventing drowse, and preparation method |
| 01/12/2005 | CN1562310A Soft capsule preparation of Tibet medicine 'unique taste' |
| 01/12/2005 | CN1562297A Combination of Chinese traditional medicine for curing vascular dementia and preparation method |
| 01/12/2005 | CN1562292A Injection of still-freeze drying powder for restoring consciousness and new preparation method |
| 01/12/2005 | CN1562281A Extract of cocoa tea in application for preparing medication of foodstuff of preventing and improving fatigue and clinical symptom |
| 01/12/2005 | CN1562265A Medicinal liquor for trating rheumatism |
| 01/12/2005 | CN1562264A Tea of sobering up, norushing stomach and protecting liver |
| 01/12/2005 | CN1562259A Fragrant pillow prepared from medicine for protecting and stengthening health |
| 01/12/2005 | CN1562228A 'Dianjian' liqid for curing epilepsy sickness |
| 01/12/2005 | CN1562224A Medication for treating painful symptoms of the illness |
| 01/12/2005 | CN1562223A Injection for curing italitai disease and preparation technique |
| 01/12/2005 | CN1562217A Aqueous extract of irid and usage |
| 01/12/2005 | CN1562216A Preparation of Chinese traditional medicine for curing cardiovascular and cerebrovascular disease and preparation method |
| 01/12/2005 | CN1562211A Drug-breaking medicine of Chinese traditional medicine |
| 01/12/2005 | CN1562187A Compound prepration of gastrodia tuber and preparation technique |
| 01/12/2005 | CN1562186A Preparation of Chinese traditional medicine for curing Illness of Cardiac cerebral ischemia and preparation method |
| 01/12/2005 | CN1562182A Preparation of Chinese traditional medicine for curing headache and preparation method |
| 01/12/2005 | CN1562144A Chinese medicinal composition for treating intestine irritable syndrome and its preparing method |
| 01/12/2005 | CN1562132A Health medicinal wine for treating panasthenia |
| 01/12/2005 | CN1562112A Medicine for treating headache |
| 01/12/2005 | CN1562105A Chinese medicine preparation for treating neruosia |
| 01/12/2005 | CN1562098A Method for preparing liver protective and sobering preparation |
| 01/12/2005 | CN1562083A Method for preparing musk freeze-dried powder injection |
| 01/12/2005 | CN1562081A Process for preparing livestock animal brain fat composite medicine |
| 01/12/2005 | CN1562073A Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/12/2005 | CN1562072A Powder injection of medium and/or low molecular weight chondroitin sulfate |
| 01/12/2005 | CN1562054A New use of caryophyllin in medicine for anti-axiety and anti-depression |
| 01/12/2005 | CN1562053A Gastrodine oral disintigration tablet with sedation hypnotic and analgesis function |
| 01/12/2005 | CN1562052A Acetyl-gastrodine oral disintigration tablet for sedation, soporific and nervous headache |
| 01/12/2005 | CN1562050A Use of oligose alginate in anti-dementia and anti-diabetes |
| 01/12/2005 | CN1562047A Glycerin invert sugar injection |
| 01/12/2005 | CN1562028A Flunarizine hydrochoride injection and preparing method |
| 01/12/2005 | CN1562023A Naloxone hydrochloride powder injection and its preparing method |
| 01/12/2005 | CN1562020A Corydalis B powder injection and its preparing method |
| 01/12/2005 | CN1562019A Corydalis B long-acting preparation and its preparing method |
| 01/12/2005 | CN1562015A Sugar-free stop-smoking lozenge |
| 01/12/2005 | CN1562010A Nimodipine injection emulsion and its preparing method |
| 01/12/2005 | CN1562008A Pyrithioxine hydrochloride injection and its preparing method |
| 01/12/2005 | CN1562007A Pyrithioxine hydrochloride freeze-dried composition and its preparing method |
| 01/12/2005 | CN1562002A Novel anti-biological cell free redical oxidation injury mixture |
| 01/12/2005 | CN1562000A 4-hydroxy-2-oxo-1-pyrrolidine acetamide freeze-dried preparation and its preparing method |
| 01/12/2005 | CN1561988A Method for preparing taxol micro ball anti-cancer medicine |
| 01/12/2005 | CN1561975A Use of central China fruit of Chinese magnoliavine ketone in preparing medicine for food for preventing and treating Alzheimer's disease |
| 01/12/2005 | CN1184321C Adenovirus-mediated gene therapy |
| 01/12/2005 | CN1184315C Death domain containing receptor 5 |
| 01/12/2005 | CN1184220C Process for preparation of 5-carboxy-phthalide and its use for production of CITALOPRAM |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/12/2005 | CN1184203C 1-benzyl-4-[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine |
| 01/12/2005 | CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 01/12/2005 | CN1183963C Method for treatment of patients afflicted with multile sclerosis using consensus interferon |
| 01/12/2005 | CN1183946C Medicines for treating depression and preparation thereof |
| 01/12/2005 | CN1183926C Cigarette for dropping drug and its preparing process |
| 01/12/2005 | CN1183921C Medicine for treating depressive via head acupoint osmosis |
| 01/12/2005 | CN1183920C Medicine for treating neurosis via head acupoint osmosis |
| 01/12/2005 | CN1183909C Medicine for dropping off drug and its preparing process |
| 01/12/2005 | CN1183907C Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
| 01/12/2005 | CN1183900C Nicotine inhaler |
| 01/12/2005 | CN1183839C Sobering-up and drunkeness-preventing liver protective beverage containing dehydrogenase |
| 01/11/2005 | US6841698 Aminopropylphosphinic acids |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841680 2-(Halophenyl)-quinoline derivatives for neuropathic pain; side effect reduction |
| 01/11/2005 | US6841679 Acylation of 2-(phenyl)-imidazo(1,2-a)pyridine derivative with oxalyl halide derivative to form anxiolytic agent; reduction, salt formation |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841571 Compounds useful as reversible inhibitors of cysteine proteases |
| 01/11/2005 | US6841569 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841557 Compounds for the treatment of addictive disorders |
| 01/11/2005 | US6841551 Administering substance P receptor antagonist selected from the group consisting of L 742694, L 758298, and LY 303241, a non-toxic magnesium compound and a pharmaceutically acceptable vehicle |
| 01/11/2005 | US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 01/11/2005 | US6841156 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion; relieving pain associated with smooth muscle disorders, including spasms in the sphincter muscles; type A & B toxins |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2215351C Process for isolating galanthamine |
| 01/11/2005 | CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 01/06/2005 | WO2005001732A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 01/06/2005 | WO2005000845A2 Bicyclic derivatives as nk-1 and nk-2 antagonists |
| 01/06/2005 | WO2005000843A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 01/06/2005 | WO2005000842A1 Benzothiazole derivatives as adenosine receptor ligands |
| 01/06/2005 | WO2005000836A1 Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 01/06/2005 | WO2005000829A1 Cannabinoid receptor modulator |
| 01/06/2005 | WO2005000825A1 Thiazolimine compound and oxazolimine compound |
| 01/06/2005 | WO2005000820A2 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists |
| 01/06/2005 | WO2005000817A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 01/06/2005 | WO2005000811A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 01/06/2005 | WO2005000809A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 01/06/2005 | WO2005000806A2 Ligands for nicotinic acetylcholine receptors, and methods of making and using them |
| 01/06/2005 | WO2005000798A1 Heterocyclic methyl sulfone derivative |
| 01/06/2005 | WO2005000791A1 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/06/2005 | WO2005000790A1 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| 01/06/2005 | WO2005000789A1 2-amino-3-alkoxybicyclo[3.1.0]hexane derivative |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2005000315A1 Combination product comprising an antagonist or inverse agonist of histamine receptor h3 and an antipsychotic or antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs |
| 01/06/2005 | WO2005000313A1 Antiepileptic agent |
| 01/06/2005 | WO2005000304A1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 01/06/2005 | WO2005000303A1 Pyrazolo`3,4-b!pyridin-6-ones as gsk-3 inhibitors |